Wakamoto Pharmaceutical Co.,Ltd. (4512.T)
Tokyo · JPY · Healthcare · Drug Manufacturers - Specialty & Generic
¥303 (+1.00%) as of
Key statistics
- Market cap
- 10.52B
- P/E (TTM)
- 30.54
- EPS (TTM)
- 9.92
- Dividend yield
- 1.17%
- 52-week range
- 240.00 – 380.00
- Beta
- 0.45
- Revenue (TTM)
- 9.43B
- Profit margin
- -2.35%
- Volume
- 27.10k
About Wakamoto Pharmaceutical Co.,Ltd.
Wakamoto Pharmaceutical Co.,Ltd. is engaged in the manufacture and sale of pharmaceuticals, medical devices, and health food in Japan. It operates through four segments: Pharmaceutical Business, Healthcare Business, Global Business, and Real Estate Leasing Business. The company offers Strong and Granule Wakamoto, gastrointestinal drugs for digestion, intestinal regulation, and nutritional supplementation, as well as Wakamoto Intestinal Remedy drug. It also provides AVANTBISE oral tablets, a supplement of bacteria to restore the balance of oral flora; and medicated toothpaste. The company was formerly known as Society for Nutrition and Raising Children Co., Ltd. and changed its name to Wakamoto Pharmaceutical Co.,Ltd. in July 1943. Wakamoto Pharmaceutical Co.,Ltd. was founded in 1929 and is headquartered in Tokyo, Japan.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Tokyo, Japan
- Employees
- 403
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.